CLINICAL TRIALS PROFILE FOR LOPURIN
✉ Email this page to a colleague
All Clinical Trials for LOPURIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00899431 ↗ | Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) | Terminated | Celgene Corporation | Phase 2 | 2009-05-06 | The goal of this clinical research study is to learn if lenalidomide, when given with a stem cell transplant and chemotherapy (bendamustine, fludarabine, and rituximab), can help to control CLL. The safety of this treatment combination will also be studied. |
NCT00899431 ↗ | Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) | Terminated | M.D. Anderson Cancer Center | Phase 2 | 2009-05-06 | The goal of this clinical research study is to learn if lenalidomide, when given with a stem cell transplant and chemotherapy (bendamustine, fludarabine, and rituximab), can help to control CLL. The safety of this treatment combination will also be studied. |
NCT01685411 ↗ | Busulfan and Cyclophosphamide Followed By ALLO BMT | Terminated | Masonic Cancer Center, University of Minnesota | N/A | 2013-01-01 | This is a treatment guideline to allow routine clinical data to be collected and maintained in Oncore (clinical database) and the University of Minnesota Blood and Marrow Database as part of the historical database maintained by the department. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOPURIN
Condition Name
Clinical Trial Locations for LOPURIN
Trials by Country
Clinical Trial Progress for LOPURIN
Clinical Trial Phase
Clinical Trial Sponsors for LOPURIN
Sponsor Name